Últimas noticias sobre Block (NYSE:XYZ) Bolsa

BLOCK INC

Block

Founded in 2009, Block provides payment services to merchants, along with related services. The company also launched Cash App, a person-to-person payment network. In 2024, Square's payment volume was almost USD 250 million.

Dorsey's Intriguing Video

News

Management

Tech

Trading Ideas

Block Inc anuncia el despido de 931 empleados. Jack Dorsey explica los motivos detrás de la decisión y el impacto en la empresa.

Block Inc (XYZ) despide al 8% de su plantilla: la estrategia detrás del recorte

Block Inc

Anacortes Mining Corp

Tidal Trust II YieldMax XYZ Option Income Strategy ETF

Needham analyst Mayank Tandon maintains Ncino (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NCNO#NASDAQ">NCNO</a>) with a Buy and lowers the price target from $45 to $28.

Price Target

Analyst Ratings

NCNO

Needham Maintains Buy on Ncino, Lowers Price Target to $28

Jones Trading analyst Justin Walsh downgrades BioLine Rx (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLRX#NASDAQ">BLRX</a>) from Buy to Hold.

Downgrades

BLRX

Jones Trading Downgrades BioLine Rx to Hold

HC Wainwright &amp; Co. analyst Ed Arce reiterates Galectin Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GALT#NASDAQ">GALT</a>) from Neutral to Neutral.

Reiteration

GALT

HC Wainwright & Co. Reiterates Neutral on Galectin Therapeuticsto Neutral

Jefferies analyst Ashley Helgans maintains PVH (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PVH#NYSE">PVH</a>) with a Hold and lowers the price target from $101 to $80.

Jefferies Maintains Hold on PVH, Lowers Price Target to $80

SVCO

Silvaco's Victory TCAD Solution Adopted By ProMOS Technologies For Next-Gen Silicon Photonics Development

HC Wainwright &amp; Co. analyst Robert Burns reiterates Elicio Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ELTX#NASDAQ">ELTX</a>) with a Buy and maintains $10 price target.

ELTX

HC Wainwright & Co. Reiterates Buy on Elicio Therapeutics, Maintains $10 Price Target

Leggett & Platt To Sell Aerospace Products Group to Tinicum for $285 M, After-tax Cash Proceeds Are Expected To Be Approximately $240M

Jefferies analyst Julien Dumoulin-Smith initiates coverage on CenterPoint Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNP#NYSE">CNP</a>) with a Buy rating and announces Price Target of $42.

Initiation

Jefferies Initiates Coverage On CenterPoint Energy with Buy Rating, Announces Price Target of $42

CME Group Q1 Average Daily Volume Up 13% YoY, March ADV Up 27% YoY

Jefferies analyst Stephen Volkmann downgrades Timken (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TKR#NYSE">TKR</a>) from Buy to Hold and lowers the price target from $90 to $70.

Jefferies Downgrades Timken to Hold, Lowers Price Target to $70

IBG: 267% &#x7C; <a href="https://www.benzinga.com//node/44603539">Innovation Beverage Group Expands U.S. Reach With Republic National Distribution Company Distribution Deal</a>
&nbsp;
SPWH: 63% &#x7C; <a href="https://www.benzinga.com//node/44594851">Sportsman's Warehouse Holdings shares are trading higher after the company reported better-than-expected Q4 financial results.</a>
&nbsp;
NCNO: -36% &#x7C; <a href="https://www.benzinga.com//node/44594847">NCino shares are trading lower after the company reported worse-than-expected Q4 adjusted EPS results and issued Q1 and FY26 guidance below estimates.</a>

Movers

SPWH

Market-Moving News for April 2nd

After 6 weeks of continued whole body application of QRX003, the subject's skin remains almost completely healed demonstrating the durability of ongoing daily treatment with the product. In addition, the patient has continued to have no requirement for previously necessary medications such as antibiotics, antivirals, antihistamines and glucocorticoids.

QNRX

Quoin Reports Additional Clinical Data From Ongoing Investigator Pediatric Netherton Syndrome Study; Reveals Continued Clear Visual Evidence Of Almost Completely Healed Skin After 6 Weeks Treatment

Award marks Bowman's fifth consecutive ADA-related contract for pedestrian infrastructure enhancements in the city

Contracts

BWMN

Bowman Wins $2.2M Contract To Design Over 1,200 ADA Curb Ramps In Philadelphia

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a<a href="https://www.benzinga.com/yield-investments"> high dividend payout</a>.
Benzinga readers can review the latest analyst takes on their favorite stocks by visiting <a href="https://www.benzinga.com/analyst-stock-ratings">Analyst Stock Ratings</a> page. Traders can sort through Benzinga's extensive database of analyst ratings, including <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">by analyst accuracy</a>.
Below are the ratings of the most accurate analysts for three high-yielding stocks in the consumer staples sector.
<h3 class="wp-block-heading">Altria Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MO#NYSE">MO</a>)</h3>
<ul>
<li>Dividend Yield: 6.94%</li>
<li>B of A Securities analyst Lisa Lewandowski upgraded the stock from Neutral to Buy and increased the price target from $55 to $65 on Dec. 6, 2024. This analyst has an accuracy rate of 66%.</li>
<li>Barclays analyst Gaurav Jain maintained an Underweight rating and raised the price target from $45 to $46 on Nov. 6, 2024. This analyst has an accuracy rate of 64%.</li>
<li>Recent News: On Jan. 30, the company posted upbeat quarterly sales.</li>
<li>Benzinga Pro&#8217;s real-time newsfeed alerted to <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0402">latest MO news</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0402"><img loading="lazy" decoding="async" width="858" height="755" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/02042845/image-21.png" alt="" class="wp-image-852766" style="width:527px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/02042845/image-21.png 858w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/02042845/image-21-300x264.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/02042845/image-21-768x676.png 768w" sizes="(max-width: 858px) 100vw, 858px" /></a></figure>
<h3 class="wp-block-heading">Walgreens Boots Alliance, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBA#NASDAQ">WBA</a>)</h3>
<ul>
<li>Dividend Yield: 8.96%</li>
<li>Deutsche Bank analyst George Hill downgraded the stock from Hold to Sell and cut the price target from $11 to $9 on Feb. 28, 2025. This analyst has an accuracy rate of 62%.</li>
<li>Truist Securities analyst David Macdonald maintained a Hold rating and cut the price target from $13 to $12 on Jan. 31, 2025. This analyst has an accuracy rate of 68%</li>
<li>Recent News: On March 6, Walgreens announced it entered into a definitive agreement to be taken private by an entity affiliated with Sycamore Partners for $10 billion.</li>
<li>Benzinga Pro's real-time newsfeed alerted to <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0402">latest WBA news</a> </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0402"><img loading="lazy" decoding="async" width="922" height="835" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/02042917/image-22.png" alt="" class="wp-image-852768" style="width:593px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/02042917/image-22.png 922w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/02042917/image-22-300x272.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/02042917/image-22-768x696.png 768w" sizes="(max-width: 922px) 100vw, 922px" /></a></figure>
<h3 class="wp-block-heading">B&amp;G Foods, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BGS#NYSE">BGS</a>)</h3>
<ul>
<li>Dividend Yield: 10.92%</li>
<li>Piper Sandler analyst Michael Lavery maintained a Neutral rating and lowered the price target from $8 to $7 on Feb. 26, 2025. This analyst has an accuracy rate of 67%.</li>
<li>Barclays analyst Brandt Montour maintained an Equal-Weight rating and cut the price target from $8 to $7 on Nov. 7, 2024. This analyst has an accuracy rate of 61%.</li>
<li>Recent News: On Feb. 25, B&amp;G Foods posted better-than-expected quarterly earnings.</li>
<li>Benzinga Pro&#8217;s real-time newsfeed alerted to latest BGS <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0402">news </a></li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0402"><img loading="lazy" decoding="async" width="920" height="836" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/02042949/image-1-4.png" alt="" class="wp-image-852769" style="width:565px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/02042949/image-1-4.png 920w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/02042949/image-1-4-300x273.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/02042949/image-1-4-768x698.png 768w" sizes="(max-width: 920px) 100vw, 920px" /></a></figure>
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="How to Find Dividend Stocks: Scan, Analyze, and Capture with Benzinga Pro" width="500" height="281" src="https://www.youtube.com/embed/pVF0O2lsEH4?start=1&#038;feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/25/04/44600914/unifirst-blackberry-and-3-stocks-to-watch-heading-into-wednesday">UniFirst, BlackBerry And 3 Stocks To Watch Heading Into Wednesday</a> </li>
</ul>
Photo via Shutterstock

Dividends

Pre-Market Outlook

Markets

Wall Street's Most Accurate Analysts Give Their Take On 3 Defensive Stocks With Over 6% Dividend Yields

Over the past week, Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>) and Shiba Inu (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/shib/usd">SHIB</a>) are down 20% and 15%, respectively, as crypto markets await the impact of <a href="https://www.benzinga.com/markets/cryptocurrency/25/04/44603859/bitcoin-braces-for-trump-tariff-announcement-short-term-optimism-has-the-upper-hand-expert">President Trump&#8217;s tariff announcements</a>.
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Price&nbsp;&nbsp;&nbsp;</td>
<td>Market Cap</td>
<td>24-Hour Trend</td>
<td>7-Day Trend</td>
</tr>
<tr>
<td>Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>)</td>
<td>$0.1724</td>
<td>$25.6 billion</td>
<td>+0.8%</td>
<td>-15.9%</td>
</tr>
<tr>
<td>Shiba Inu (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/shib/usd">SHIB</a>)</td>
<td>$0.00001233&nbsp;&nbsp;</td>
<td>$7.26 billion</td>
<td>-3.3%</td>
<td>-20.3%</td>
</tr>
<tr>
<td>Pepe (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">PEPE</a>)</td>
<td>$0.057391</td>
<td>$3.1 billion</td>
<td>-2.4%</td>
<td>-19.2%</td>
</tr>
</tbody>
</table>
</figure>
Trader Notes: Crypto trader Nebraskangooner noted that SHIB's recent breakout was a fakeout, with many altcoins hitting resistance and retracing
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><a href="https://twitter.com/search?q=%24SHIB&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$SHIB</a> (per request) Pretty nasty fake break out.. many other alts have rejected resistance and headed back to the lows from here. <a href="https://t.co/cJmyHHahgh">pic.twitter.com/cJmyHHahgh</a>
&mdash; Nebraskangooner (@Nebraskangooner) <a href="https://twitter.com/Nebraskangooner/status/1907170918079635544?ref_src=twsrc%5Etfw">April 1, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Crypto chart analyst Ali Martinez <a href="https://x.com/ali_charts/status/1907171359811383352">sees</a> Dogecoin trading near support, with the TD Sequential indicator flashing a buy signal—suggesting a potential bullish reversal.
Trader Byzantine General <a href="https://x.com/ByzGeneral/status/1907212687957790790">remains</a> bullish on meme coins with strong brand recognition, predicting they could be forming cycle bottoms.
Statistics: Shibburn data shows 115.9 million SHIB coins have been removed from circulation over the past 24 hours, increasing the burn rate by 104,201.4%. 
One transaction burned 92.6 million SHIB around nine hours ago. 
IntoTheBlock data shows SHIB large transaction volume and daily active addresses down by 53.3% and 32.8%, respectively. Transactions greater than $100,000 declined from 74 to 54.
DOGE long liquidations declined from $1.72 million to $1.43 million on Tuesday.
Read Next:&nbsp;
<ul>
<li><a href="https://in.benzinga.com/markets/cryptocurrency/25/03/44456360/dogecoin-shiba-inu-up-3-and-flashing-bullish-signals-is-a-rally-coming">Dogecoin, Shiba Inu Up 3% And Flashing Bullish Signals—Is A Rally Coming?</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$DOGE

$PEPE

$SHIB

Why Are Dogecoin, Shiba Inu Down Over 15% In The Past Week?

Under this new program, Spectrum Reserve is expected to introduce new strains on a regular basis based on patient needs, preferences, and feedback.
This approach will help Spectrum Therapeutics consistently deliver new, premium quality strains to the medical cannabis market in Canada.

Canopy Growth Launches Spectrum Reserve, A New Premium Medical Cannabis Brand In Canada

U.S. stock futures were lower this morning, with the Dow futures falling more than 50 points on Wednesday.
Shares of nCino, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NCNO#NASDAQ">NCNO</a>) fell sharply in today's pre-market trading after the company reported <a href="https://in.benzinga.com/news/earnings/25/04/44595568/ncino-stock-plunges-after-worse-than-expected-q4-eps-weak-forward-guidance">weaker-than-expected earnings for its fourth quarter.</a>
The company also said it sees first-quarter total revenues of $138.75 million to $140.75 million and adjusted earnings of 15 cents to 16 cents per share.&nbsp;&nbsp;&nbsp;&nbsp;
nCino shares dipped 31.5% to $19.30 in the pre-market trading session.
Here are some other stocks moving lower in pre-market trading.
<ul>
<li>Jayud Global Logistics Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JYD#NASDAQ">JYD</a>) shares fell 78.3% to $0.3490 in pre-market trading.</li>
<li>Waton Financial Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WTF#NASDAQ">WTF</a>) shares tumbled 28% to $14.30 in pre-market trading after jumping 396% on Tuesday.</li>
<li>Rapport Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RAPP#NASDAQ">RAPP</a>) shares dipped 24.7% to $7.20 in pre-market trading following a 5% decline on Tuesday.</li>
<li>Newsmax, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NMAX#NYSE">NMAX</a>) shares fell 21.2% to $183.73 in pre-market trading. Newsmax shares surged 179% on Tuesday on continued IPO launch strength.</li>
<li>Regencell Bioscience Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGC#NASDAQ">RGC</a>) shares declined 9.6% to $26.21 in pre-market trading after falling 9% on Tuesday.</li>
<li>Microvast Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MVST#NASDAQ">MVST</a>) declined 7.7% to $1.43 in pre-market trading. Microvast Holdings shares jumped 32% on Tuesday after the company reported better-than-expected fourth-quarter financial results.</li>
<li>National CineMedia, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NCMI#NASDAQ">NCMI</a>) fell 5.8% to $5.63 in pre-market trading.</li>
<li>MeridianLink, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MLNK#NYSE">MLNK</a>) fell 5.7% to $17.70 in pre-market trading.</li>
<li>Hims &amp; Hers Health, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HIMS#NYSE">HIMS</a>) dipped 5.2% to $29.45 in pre-market trading. Hims &amp; Hers Health shares gained 5% on Tuesday after the company announced it added Lilly&#8217;s Zepbound to its telehealth platform.</li>
<li>Tesla, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) fell 2.4% to $261.95 in pre-market trading. Tesla's sales in key European markets continued their downward trend in March, extending losses for a third consecutive month in multiple countries as the electric vehicle maker faces mounting challenges from Chinese competition and backlash against CEO Elon Musk‘s political activities</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/25/04/44600914/unifirst-blackberry-and-3-stocks-to-watch-heading-into-wednesday">UniFirst, BlackBerry And 3 Stocks To Watch Heading Into Wednesday</a></li>
</ul>
Photo via Shutterstock

Hims & Hers Health, Inc. Class A Common Stock

HIMS

MLNK

MVST

NCMI

NMAX

RAPP

TSLA

nCino Posts Weak Earnings, Joins Tesla And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

BIIB

Biogen Says FDA Granted Fast Track Designation To BIIB080, An Investigational Antisense Oligonucleotide Therapy Targeting Tau, For Treatment Of Alzheimer's Disease

Needham analyst Bernie McTernan reiterates Sportradar Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRAD#NASDAQ">SRAD</a>) with a Buy and maintains $27 price target.

SRAD

Needham Reiterates Buy on Sportradar Gr, Maintains $27 Price Target

The most oversold stocks in the utilities sector presents an opportunity to buy into undervalued companies.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the<a href="https://www.benzinga.com/topic/rsi"> RSI is below 30</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>.
Here's the latest list of major oversold players in this sector, having an RSI near or below 30.
<h3 class="wp-block-heading">Sunnova Energy International Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOVA#NYSE">NOVA</a>)</h3>
<ul>
<li>On April 1, Sunnova named Robyn Liska as interim CFO. &#8220;Robyn has deep industry knowledge and a proven record of driving financial transformation,&#8221; said Paul Mathews, Sunnova Chief Executive Officer. &#8220;Her expertise will be invaluable as we continue to work to stabilize our foundation, sharpen our execution, and position Sunnova to succeed in today&#8217;s evolving solar energy market.&#8221; The company's stock fell around 44% over the past month and has a 52-week low of $0.25.</li>
<li>RSI Value: 26.3</li>
<li>NOVA Price Action: Shares of Sunnova Energy fell 11.3% to close at $0.33 on Tuesday.</li>
<li>Edge Stock Ratings: 0.48 Momentum score with Value at 89.09. </li>
</ul>
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/quote/NOVA"><img loading="lazy" decoding="async" width="427" height="177" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/02035323/image-18.png" alt="" class="wp-image-852699" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/02035323/image-18.png 427w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/02035323/image-18-300x124.png 300w" sizes="(max-width: 427px) 100vw, 427px" /></a></figure>
<h3 class="wp-block-heading">Cadiz Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDZI#NASDAQ">CDZI</a>)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</h3>
<ul>
<li>On March 7, Cadiz Inc. announced a $20 million registered direct offering. The offering involves the sale of 5,715,000 shares of its common stock at $3.50 per share. The company expects to use the net proceeds for capital and other expenses related to the development and construction of its Mojave Groundwater Bank project.. The company's stock fell around 28% over the past month and <a href="https://www.benzinga.com/quote/CDZI">has a 52-week low</a> of $2.12.</li>
<li>RSI Value: 29</li>
<li>CDZI Price Action: Shares of Cadiz gained 0.7% to close at $2.95 on Tuesday.</li>
<li>Benzinga Pro&#8217;s charting tool helped identify the trend in <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0402">CDZI stock</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0402"><img loading="lazy" decoding="async" width="918" height="827" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/02035456/image-19.png" alt="" class="wp-image-852702" style="width:546px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/02035456/image-19.png 918w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/02035456/image-19-300x270.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/02035456/image-19-768x692.png 768w" sizes="(max-width: 918px) 100vw, 918px" /></a></figure>
<h3 class="wp-block-heading">Spruce Power Holding Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPRU#NYSE">SPRU</a>)</h3>
<ul>
<li>On March 31, Spruce Power Holding reported a quarterly loss of 29 cents per share, versus a year-ago loss of $1.60 per share. &#8220;In this time of heightened uncertainty across the residential solar market, Spruce offers investors greater stability and predictability given that our business is predicated on generating long-term contracted cash flows from existing solar assets through operational efficiencies, maintenance and superior asset management,&#8221; said Chris Hayes, Spruce&#8217;s Chief Executive Officer. The company's stock fell around 20% over the past five days and has a 52-week<a href="https://www.benzinga.com/quote/SPRU"> low of $2.08.</a></li>
<li>RSI Value: 25.4</li>
<li>SPRU Price Action: Shares of Spruce Power fell 12% to close at $2.12 on Tuesday.</li>
<li>Benzinga Pro&#8217;s signals feature notified of a potential breakout in <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0402">SPRU shares</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0402"><img loading="lazy" decoding="async" width="870" height="820" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/02035518/image-1-3.png" alt="" class="wp-image-852703" style="width:516px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/02035518/image-1-3.png 870w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/02035518/image-1-3-300x283.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/02035518/image-1-3-768x724.png 768w" sizes="(max-width: 870px) 100vw, 870px" /></a></figure>
Learn more about BZ Edge Rankings—click to see scores for other stocks in the sector and s<a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">ee how they compare.</a> 
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/25/04/44584246/wall-streets-most-accurate-analysts-give-their-take-on-3-consumer-stocks-delivering-high-dividend-yields-6">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Consumer Stocks Delivering High-Dividend Yields</a> </li>
</ul>
Photo via Shutterstock

Long Ideas

CDZI

NOVA

Spruce Power Holding Corporation Class A Common Stock

Comments

Block

Noticias

Últimas noticias sobre Block (NYSE:XYZ) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL